Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Apr;16(4):25.
doi: 10.1007/s11892-016-0719-5.

Intensive Glycemic Control in Cardiac Surgery

Affiliations
Review

Intensive Glycemic Control in Cardiac Surgery

Lillian L Tsai et al. Curr Diab Rep. 2016 Apr.

Abstract

Hyperglycemia has been found to be associated with increased morbidity and mortality in surgical patients, yet, the optimal glucose management strategy during the perioperative setting remains undetermined. While much has been published about hyperglycemia and cardiac surgery, most studies have used widely varying definitions of hyperglycemia, methods of insulin administration, and the timing of therapy. This has only allowed investigators to make general conclusions in this challenging clinical scenario. This review will introduce the basic pathophysiology of hyperglycemia in the cardiac surgery setting, describe the main clinical consequences of operative hyperglycemia, and take the reader through the published material of intensive and conservative glucose management. Overall, it seems that intensive control has modest benefits with adverse effects often outweighing these advantages. However, some studies have indicated differing results for certain patient subgroups, such as non-diabetics with acute operative hyperglycemia. Future studies should focus on distinguishing which patient populations, if any, would optimally benefit from intensive insulin therapy.

Keywords: Cardiac surgery; Glucose management; Hyperglycemia; Outcomes.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Curr Opin Endocrinol Diabetes Obes. 2011 Apr;18(2):110-8 - PubMed
    1. J Diabetes Complications. 2014 Jul-Aug;28(4):427-9 - PubMed
    1. Mayo Clin Proc. 2005 Jul;80(7):862-6 - PubMed
    1. Am J Med. 1995 Jan;98(1):75-84 - PubMed
    1. Chest. 2010 Mar;137(3):544-51 - PubMed

LinkOut - more resources